Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Collagen type III is a major fibrillar collagen that is a key component of the extracellular matrix (ECM) in various tissues, including skin, blood vessels, and internal organs. It is composed of three alpha-1(III) chains and plays a critical role in maintaining tissue integrity and elasticity. In therapeutic and biomedical research, collagen III is investigated for its ability to modulate the tumor microenvironment, promote wound healing, and serve as a scaffold for tissue engineering. It interacts with cell surface receptors such as integrins and discoidin domain receptors to influence cellular behaviors like adhesion, migration, and proliferation. In the context of oncology, it has been shown to influence tumor angiogenesis and growth when present in the tumor stroma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on collagen type III.